Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors $19.50 +2.09 (+12.00%) Closing price 04:00 PM EasternExtended Trading$19.39 -0.11 (-0.59%) As of 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsTrends TLX vs. ONC, TEVA, SMMT, GMAB, ITCI, VTRS, MRNA, RDY, PCVX, and SRPTShould you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Beigene (ONC), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Intra-Cellular Therapies (ITCI), Viatris (VTRS), Moderna (MRNA), Dr. Reddy's Laboratories (RDY), Vaxcyte (PCVX), and Sarepta Therapeutics (SRPT). These companies are all part of the "pharmaceutical products" industry. Telix Pharmaceuticals Limited American Depositary Shares vs. Beigene Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Intra-Cellular Therapies Viatris Moderna Dr. Reddy's Laboratories Vaxcyte Sarepta Therapeutics Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) and Beigene (NASDAQ:ONC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, community ranking, risk, earnings and media sentiment. Does the MarketBeat Community prefer TLX or ONC? Telix Pharmaceuticals Limited American Depositary Shares received 3 more outperform votes than Beigene when rated by MarketBeat users. CompanyUnderperformOutperformTelix Pharmaceuticals Limited American Depositary SharesOutperform Votes3100.00% Underperform VotesNo VotesBeigeneN/AN/A Do insiders and institutionals have more ownership in TLX or ONC? 48.6% of Beigene shares are owned by institutional investors. 7.4% of Beigene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is TLX or ONC more profitable? Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Beigene's net margin of -25.94%. Telix Pharmaceuticals Limited American Depositary Shares' return on equity of 0.00% beat Beigene's return on equity.Company Net Margins Return on Equity Return on Assets Telix Pharmaceuticals Limited American Depositary SharesN/A N/A N/A Beigene -25.94%-25.12%-14.95% Do analysts recommend TLX or ONC? Telix Pharmaceuticals Limited American Depositary Shares presently has a consensus target price of $22.00, suggesting a potential upside of 12.82%. Given Telix Pharmaceuticals Limited American Depositary Shares' stronger consensus rating and higher probable upside, research analysts clearly believe Telix Pharmaceuticals Limited American Depositary Shares is more favorable than Beigene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Beigene 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer TLX or ONC? In the previous week, Telix Pharmaceuticals Limited American Depositary Shares had 2 more articles in the media than Beigene. MarketBeat recorded 5 mentions for Telix Pharmaceuticals Limited American Depositary Shares and 3 mentions for Beigene. Beigene's average media sentiment score of 0.37 beat Telix Pharmaceuticals Limited American Depositary Shares' score of 0.28 indicating that Beigene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Telix Pharmaceuticals Limited American Depositary Shares 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Beigene 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, TLX or ONC? Telix Pharmaceuticals Limited American Depositary Shares has higher earnings, but lower revenue than Beigene. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelix Pharmaceuticals Limited American Depositary SharesN/AN/AN/AN/AN/ABeigene$2.46B10.16-$881.71M-$8.24-30.99 SummaryTelix Pharmaceuticals Limited American Depositary Shares beats Beigene on 9 of the 13 factors compared between the two stocks. Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLX vs. The Competition Export to ExcelMetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.57B$7.04B$5.77B$8.95BDividend YieldN/A2.87%4.78%3.85%P/E RatioN/A6.1326.4918.81Price / SalesN/A314.26449.1576.66Price / CashN/A67.8344.0437.47Price / BookN/A6.747.634.64Net IncomeN/A$138.11M$3.18B$245.69M7 Day Performance13.44%-2.02%-1.82%-2.64%1 Month Performance15.66%-1.54%0.22%-2.37%1 Year PerformanceN/A-3.14%17.49%13.63% Telix Pharmaceuticals Limited American Depositary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$19.50+12.0%$22.00+12.8%N/A$6.57BN/A0.00N/ANews CoverageGap UpHigh Trading VolumeONCBeigeneN/A$230.86+2.4%N/AN/A$22.56B$2.46B-28.0210,600Insider TradeNews CoverageGap UpTEVATeva Pharmaceutical Industries2.8879 of 5 stars$16.24-2.4%$23.57+45.2%+30.1%$18.39B$16.54B-11.2037,851SMMTSummit Therapeutics2.3035 of 5 stars$21.37-2.1%$33.57+57.1%+516.6%$15.76B$700,000.00-76.32110Gap UpGMABGenmab A/S4.5897 of 5 stars$21.30+1.8%$42.17+98.0%-22.5%$14.10B$2.39B20.682,204ITCIIntra-Cellular Therapies3.9215 of 5 stars$127.82-0.2%$103.62-18.9%+74.4%$13.59B$464.37M-146.92560Earnings ReportAnalyst ForecastNews CoverageVTRSViatris2.3252 of 5 stars$10.80flat$13.67+26.5%-16.5%$12.89B$15.43B-14.5938,000News CoverageMRNAModerna4.7389 of 5 stars$32.99+3.4%$66.89+102.8%-61.2%$12.70B$6.85B-5.675,600Analyst DowngradeOptions VolumeHigh Trading VolumeRDYDr. Reddy's Laboratories2.8624 of 5 stars$13.60-2.8%$17.00+25.0%-11.7%$11.35B$311.31B21.6527,048Gap DownPCVXVaxcyte2.5867 of 5 stars$84.00+0.2%$127.71+52.0%+11.3%$10.47BN/A-18.26160Insider TradePositive NewsSRPTSarepta Therapeutics4.4962 of 5 stars$107.95-1.4%$176.77+63.8%-20.4%$10.31B$1.24B86.361,314Upcoming Earnings Related Companies and Tools Related Companies ONC Alternatives TEVA Alternatives SMMT Alternatives GMAB Alternatives ITCI Alternatives VTRS Alternatives MRNA Alternatives RDY Alternatives PCVX Alternatives SRPT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
